Sunday, September 23, 2018
Close  
  • share this

Study: Hormone-blocker slashes breast cancer risk

/ 11:16 PM December 12, 2013

In this Thursday, Sept. 5, 2013 photo, chemotherapy is administered to a cancer patient via intravenous drip at Duke Cancer Center in Durham, N.C. AP

SAN ANTONIO — Women at high risk of developing breast cancer because of family history or bad genes have a new option to help prevent the disease.

A study of 4,000 women found that a daily hormone-blocking pill cut the risk of developing breast cancer by more than half after five years of use.

ADVERTISEMENT

The drug is anastrozole, sold as Arimidex and in generic form. It can cause hot flashes, joint pain and other side effects, but these were nearly as common among women given dummy pills and are often due to menopause and aging.

Results were reported Thursday at a cancer conference in San Antonio.

Read Next
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Arimidex, Breast Cancer, Cancer Patient, Chemotherapy, Health Science
For feedback, complaints, or inquiries, contact us.
newsinfo

1 dead, 2 hurt in Isabela road accident

September 23, 2018 06:41 PM

sports

Baltazar, Melecio lead La Salle past winless UE

September 23, 2018 06:37 PM



© Copyright 1997-2018 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.